These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35338956)

  • 1. ABCG2, SCN1A and CYP3A5 genes polymorphism and drug-resistant epilepsy in children: A case-control study.
    Mousavi SF; Hasanpour K; Nazarzadeh M; Adli A; Bazghandi MS; Asadi A; Rad A; Gholami O
    Seizure; 2022 Apr; 97():58-62. PubMed ID: 35338956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children.
    Abo El Fotoh WM; Abd El Naby SA; Habib MS; ALrefai AA; Kasemy ZA
    Seizure; 2016 Oct; 41():75-80. PubMed ID: 27498208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Genetic Polymorphism of
    Tang HX; Ho MD; Vu NP; Cao HV; Ngo VA; Nguyen VT; Nguyen TD; Nguyen TD
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674283
    [No Abstract]   [Full Text] [Related]  

  • 4. Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis.
    Zhao GX; Zhang Z; Cai WK; Shen ML; Wang P; He GH
    Epilepsy Res; 2021 Jul; 173():106615. PubMed ID: 33756436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between SCN1A gene polymorphisms and drug resistant epilepsy in pediatric patients.
    Margari L; Legrottaglie AR; Vincenti A; Coppola G; Operto FF; Buttiglione M; Cassano A; Bartolomeo N; Mariggiò MA
    Seizure; 2018 Feb; 55():30-35. PubMed ID: 29353705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Base Gene Variants in
    Buainain RP; Sodré AR; Dos Santos JS; Takazaki KAG; Queiroz LS; de Oliveira CTP; de Aguiar PHP; Marson FAL; Ortega MM
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of UGT2B7, SCN1A and CYP3A4 on the therapeutic response of sodium valproate treatment in children with generalized seizures.
    Feng W; Mei S; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Seizure; 2018 May; 58():96-100. PubMed ID: 29679912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of SCN1A p.Thr1067Ala polymorphism with epilepsy risk and the response to antiepileptic drugs in Slovenian children and adolescents with epilepsy.
    Bertok S; Dolžan V; Goričar K; Podkrajšek KT; Battelino T; Rener-Primec Z
    Seizure; 2017 Oct; 51():9-13. PubMed ID: 28753467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of genetic polymorphisms on imatinib concentration and therapeutic response in patients with chronic-phase chronic myeloid leukemia.
    Cheng F; Cui Z; Li Q; Chen S; Li W; Zhang Y
    Int Immunopharmacol; 2024 May; 133():112090. PubMed ID: 38640718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.
    Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z
    Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children.
    Liu M; Mao J; Xu H; Wang J; Zhao P; Xu Q; Du Z
    Epilepsy Res; 2020 Dec; 168():106485. PubMed ID: 33096315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.
    Haerian BS; Baum L; Kwan P; Tan HJ; Raymond AA; Mohamed Z
    Pharmacogenomics; 2013 Jul; 14(10):1153-66. PubMed ID: 23859570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady-state disposition of lamotrigine in adults with epilepsy.
    Klarica Domjanović I; Lovrić M; Trkulja V; Petelin-Gadže Ž; Ganoci L; Čajić I; Božina N
    Br J Clin Pharmacol; 2018 Sep; 84(9):2106-2119. PubMed ID: 29791014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between SCN1A polymorphism and carbamazepine responsiveness in epilepsy: A meta-analysis.
    Zhang X; Liu J; Ye J
    Epilepsy Res; 2021 Oct; 176():106627. PubMed ID: 34218210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of the sodium voltage-gated channel, alpha subunit 1 (SCN1A -A3184G) gene among children with non-lesional epilepsy: a case-control study.
    Ghazala E; Shahin DA; Wahba Y
    Ital J Pediatr; 2022 Sep; 48(1):157. PubMed ID: 36056404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients.
    Zhang ML; Chen XL; Bai ZF; Zhao X; Li WX; Wang XY; Zhang H; Chen XF; Zhang SQ; Tang JF; Xiao XH; Zhao YL
    Gene; 2021 Dec; 805():145907. PubMed ID: 34411648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCN1A Polymorphisms and Haplotypes Are Associated With Valproic Acid Treatment Outcomes in Chinese Children With Epilepsy.
    Zhu J; Lu J; Shen X; He Y; Xia H; Li W; Guo H; Zhang J; Fan X
    Pediatr Neurol; 2023 Sep; 146():55-64. PubMed ID: 37451178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic insights into ABCB1, ABCC2, CYP1A2, and CYP2B6 variants with epilepsy susceptibility among Egyptian Children: A retrospective case-control study.
    Attia ZR; Labib ME; Kelany AK; Alnefaie RM; Twab HA; Wahsh E; Abd El Azeem RA; Shaaban EIA; Elsaid AM; Alalawy AI; Elshazli RM; El Tantawi N
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113073. PubMed ID: 39265352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Analysis of Sodium Channel Genes in Pediatric Epilepsy Patients of Pakistan.
    Ashfaq A; Saleem T; Sheikh N; Maqbool H
    Genet Res (Camb); 2022; 2022():1168703. PubMed ID: 35136380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.
    Ma CL; Wu XY; Zheng J; Wu ZY; Hong Z; Zhong MK
    Pharmacogenomics; 2014 Jul; 15(10):1323-36. PubMed ID: 25155934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.